Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nature ; 609(7926): 369-374, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-36045296

RESUMEN

Recently, chimeric antigen receptor (CAR)-T cell therapy has shown great promise in treating haematological malignancies1-7. However, CAR-T cell therapy currently has several limitations8-12. Here we successfully developed a two-in-one approach to generate non-viral, gene-specific targeted CAR-T cells through CRISPR-Cas9. Using the optimized protocol, we demonstrated feasibility in a preclinical study by inserting an anti-CD19 CAR cassette into the AAVS1 safe-harbour locus. Furthermore, an innovative type of anti-CD19 CAR-T cell with PD1 integration was developed and showed superior ability to eradicate tumour cells in xenograft models. In adoptive therapy for relapsed/refractory aggressive B cell non-Hodgkin lymphoma (ClinicalTrials.gov, NCT04213469 ), we observed a high rate (87.5%) of complete remission and durable responses without serious adverse events in eight patients. Notably, these enhanced CAR-T cells were effective even at a low infusion dose and with a low percentage of CAR+ cells. Single-cell analysis showed that the electroporation method resulted in a high percentage of memory T cells in infusion products, and PD1 interference enhanced anti-tumour immune functions, further validating the advantages of non-viral, PD1-integrated CAR-T cells. Collectively, our results demonstrate the high safety and efficacy of non-viral, gene-specific integrated CAR-T cells, thus providing an innovative technology for CAR-T cell therapy.


Asunto(s)
Inmunoterapia Adoptiva , Linfoma de Células B , Receptores Quiméricos de Antígenos , Animales , Antígenos CD19/inmunología , Electroporación , Humanos , Inmunoterapia Adoptiva/efectos adversos , Inmunoterapia Adoptiva/métodos , Linfoma de Células B/inmunología , Linfoma de Células B/patología , Linfoma de Células B/terapia , Células T de Memoria/inmunología , Receptor de Muerte Celular Programada 1/inmunología , Receptores Quiméricos de Antígenos/inmunología , Receptores Quiméricos de Antígenos/uso terapéutico , Recurrencia , Análisis de la Célula Individual , Ensayos Antitumor por Modelo de Xenoinjerto
2.
Comput Intell Neurosci ; 2022: 2594430, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35958747

RESUMEN

Table tennis is China 's national game and the proudest sport in China's sports field. During the research and technology service work of the Chinese table tennis team for many years, it has accumulated a large amount of valuable data on the analysis of skills and tactics of training and matches, match video, training monitoring, and so on. This paper discusses the relevant theory of swarm intelligence algorithm processing big data on the table tennis training competition knowledge interaction platform system, as well as the technical support of Nginx and Tomcat, and determines the technical basis of the table tennis training competition knowledge interaction platform. Through the establishment of the firefly algorithm model, the resource search ability is enhanced, and the traditional firefly algorithm is improved. From the results of the system performance test, it can be found that the improved swarm intelligence algorithm adopted in this paper improves the global convergence, and the load balancing degree gradually decreases with the increase of time. The improved firefly algorithm shows good performance when the bandwidth is low, and the resource occupancy rate is greatly reduced. When the bandwidth is 20, it is reduced by 12.55%. It solves the shortcomings of long time and low success rate, so as to verify the convenience of the system operation and the power of functions and make the platform more intelligent and efficient.


Asunto(s)
Rendimiento Atlético , Tenis , Algoritmos , Inteligencia , Conocimiento
3.
Front Pharmacol ; 12: 680081, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34290609

RESUMEN

Metabolism-associated fatty liver disease (MAFLD) is the most common chronic liver disease worldwide, and the use of traditional Chinese medicines (TCMs) to treat this disease has attracted increasing attention. The Qing Gan San (QGS) formula comprises Polygonatum sibiricum, the peel of Citrus reticulata Blanco, the leaves of Morus alba L, Cichorium intybus, Glycyrrhiza uralensis Fisch, and Cirsium setosum. The present study aimed to uncover the anti-hyperlipidaemic effects, hepatic fat accumulation-lowering effects and mechanisms of QGS in high-fat diet-induced MAFLD rats. QGS significantly reduced the levels of total cholesterol and triglycerides in both serum and liver tissue and partially protected hepatic function. Additionally, QGS significantly ameliorated hepatic lipid accumulation with histopathology observation, as demonstrated by H&E and oil red O staining. RNA sequencing was used to further investigate the key genes involved in the development and treatment of MAFLD. Hierarchical clustering analysis showed that the gene expression profiles in rats with MAFLD were reversed to normal after QGS treatment. QGS had 222 potential therapeutic targets associated with MAFLD. Enrichment analysis among these targets revealed that QGS affected biological functions/pathways such as the regulation of lipid metabolic processes (GO: 0019216) and the non-alcoholic fatty liver disease pathway (hsa04932), and identified Srebp-1 as a key regulator in the synthesis of cholesterol and triglycerides. Subsequently, both immunofluorescence and Western blot analyses demonstrated that QGS suppressed the transfer of Srebp-1 to the nucleus from the cytoplasm, suggesting that the activation of Srebp-1 was inhibited. Our study reveals the effects and mechanisms of QGS in the treatment of MAFLD and provides insights and prospects to further explore the pathogenesis of MAFLD and TCM therapies.

4.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi ; 30(5): 612-5, 2013 Oct.
Artículo en Chino | MEDLINE | ID: mdl-24078583

RESUMEN

OBJECTIVE: To analyze the clinical effect of fetal chromosomal reciprocal translocation in order to optimize procedures for prenatal diagnosis and clinical counseling. METHODS: Conventional G-banding karyotype analysis was performed on 7901 amniotic fluid samples. For fetuses found to have carried a reciprocal translocation, karyotypes of their parents were checked. Fetuses with de novo translocations also underwent microarray analysis to exclude small deletions, and were subjected to prenatal ultrasound monitoring till birth and one year follow-up. Those with de novo translocations were followed till 3 years old. RESULTS: A total of 24 fetal reciprocal translocations have been identified, which gave a detection rate of 0.30%. Analysis of parental karyotypes has found reciprocal translocations in 17 cases, including 9 maternal and 8 paternal cases. The remaining 4 were of de novo mutations, for which parental examination was refused in three cases. For fetuses with inherited translocations, prenatal ultrasound monitoring and follow-up results were all normal. For those with de novo translocations, although gene chip analysis has failed to detect copy number variations (CNVs), prenatal ultrasound and follow-up results had found three with abnormal outcome. These included 1 case with reciprocal translocation involving the X chromosome and an autosome. CONCLUSION: For prenatally detected reciprocal chromosome translocations, parental origin should be traced. Gene chip analysis can help to exclude small deletions and duplications. However, ultrasound monitoring and follow-up after birth are equally important. Based on comprehensive analysis of the results of combined testing, accurate counseling can be provided.


Asunto(s)
Enfermedades Fetales/diagnóstico , Enfermedades Fetales/genética , Translocación Genética , Adulto , Líquido Amniótico/citología , Bandeo Cromosómico , Femenino , Feto/citología , Asesoramiento Genético , Humanos , Masculino , Embarazo , Diagnóstico Prenatal , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...